Matt Larew

Matt Larew

Research Analyst

Chicago skyline

About Matt

Matt Larew, partner, joined William Blair in 2012 and covers life science tools and healthcare delivery. In 2018, Institutional Investor named Matt a Rising Star for the All-America Research Team. In the 2019 StarMine Analyst Awards from Refinitiv, Matt was ranked the No. 3 stock picker for healthcare providers and services. Before receiving an M.B.A. in finance and a Master of Health Administration from the University of Iowa, Matt completed his undergraduate studies at the University of Notre Dame, where he earned a B.S. in biological sciences. Matt worked as a research assistant at the University of Iowa Bone Healing Research Lab before pursuing his graduate degrees.

Coverage List

About William Blair

William Blair is a premier global boutique with expertise in investment banking, investment management, and private wealth management. We provide advisory services, strategies, and solutions to meet our clients’ evolving needs. As an independent and employee-owned firm, together with our strategic partners, we operate in more than 20 offices worldwide.*

William Blair Emblem

Year William Blair was founded

Icon of three people

Employees worldwide

Dollar sign icon
+108 billion

Client assets

Handshake icon
87 Years

Independent and employee-owned

Globe icon

Offices worldwide

Checklist icon

Companies under coverage

As of June 30, 2022
*Includes strategic partnerships with Allier Capital, BDA Partners, and Poalim Capital Markets.

More about William Blair affiliated entities

This content is for informational and educational purposes only and not intended as investment advice or a recommendation to buy or sell any security. Investment advice and recommendations can be provided only after careful consideration of an investor's objectives, guidelines, and restrictions.

Copyright © 2022 William Blair & Company, L.L.C. | Privacy Terms

Are you sure you want to leave?

Information contained on the internet is not subject to William Blair & Company's control or review, and may not be accurate.

For disclosure information, please visit